429 related articles for article (PubMed ID: 19141765)
1. Neurodevelopmental outcomes of preterm infants fed high-dose docosahexaenoic acid: a randomized controlled trial.
Makrides M; Gibson RA; McPhee AJ; Collins CT; Davis PG; Doyle LW; Simmer K; Colditz PB; Morris S; Smithers LG; Willson K; Ryan P
JAMA; 2009 Jan; 301(2):175-82. PubMed ID: 19141765
[TBL] [Abstract][Full Text] [Related]
2. Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial.
Collins CT; Gibson RA; Anderson PJ; McPhee AJ; Sullivan TR; Gould JF; Ryan P; Doyle LW; Davis PG; McMichael JE; French NP; Colditz PB; Simmer K; Morris SA; Makrides M
BMJ Open; 2015 Mar; 5(3):e007314. PubMed ID: 25787990
[TBL] [Abstract][Full Text] [Related]
3. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
[TBL] [Abstract][Full Text] [Related]
4. Pre- and post-term growth in pre-term infants supplemented with higher-dose DHA: a randomised controlled trial.
Collins CT; Makrides M; Gibson RA; McPhee AJ; Davis PG; Doyle LW; Simmer K; Colditz PB; Morris S; Sullivan TR; Ryan P
Br J Nutr; 2011 Jun; 105(11):1635-43. PubMed ID: 21443815
[TBL] [Abstract][Full Text] [Related]
5. Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial.
O'Connor DL; Hall R; Adamkin D; Auestad N; Castillo M; Connor WE; Connor SL; Fitzgerald K; Groh-Wargo S; Hartmann EE; Jacobs J; Janowsky J; Lucas A; Margeson D; Mena P; Neuringer M; Nesin M; Singer L; Stephenson T; Szabo J; Zemon V;
Pediatrics; 2001 Aug; 108(2):359-71. PubMed ID: 11483801
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants.
Fewtrell MS; Morley R; Abbott RA; Singhal A; Isaacs EB; Stephenson T; MacFadyen U; Lucas A
Pediatrics; 2002 Jul; 110(1 Pt 1):73-82. PubMed ID: 12093949
[TBL] [Abstract][Full Text] [Related]
7. Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial.
Smithers LG; Collins CT; Simmonds LA; Gibson RA; McPhee A; Makrides M
Am J Clin Nutr; 2010 Mar; 91(3):628-34. PubMed ID: 20053878
[TBL] [Abstract][Full Text] [Related]
8. Effect of Early Prophylactic High-Dose Recombinant Human Erythropoietin in Very Preterm Infants on Neurodevelopmental Outcome at 2 Years: A Randomized Clinical Trial.
Natalucci G; Latal B; Koller B; Rüegger C; Sick B; Held L; Bucher HU; Fauchère JC;
JAMA; 2016 May; 315(19):2079-85. PubMed ID: 27187300
[TBL] [Abstract][Full Text] [Related]
9. Respiratory hospitalisation of infants supplemented with docosahexaenoic acid as preterm neonates.
Atwell K; Collins CT; Sullivan TR; Ryan P; Gibson RA; Makrides M; McPhee AJ
J Paediatr Child Health; 2013 Jan; 49(1):E17-22. PubMed ID: 23279074
[TBL] [Abstract][Full Text] [Related]
10. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial.
Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG
BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059
[TBL] [Abstract][Full Text] [Related]
11. The effect of supplementation of docosahexaenoic acid and arachidonic acid on visual acuity and neurodevelopment in larger preterm infants.
Fang PC; Kuo HK; Huang CB; Ko TY; Chen CC; Chung MY
Chang Gung Med J; 2005 Oct; 28(10):708-15. PubMed ID: 16382755
[TBL] [Abstract][Full Text] [Related]
12. Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trial.
Gunaratne AW; Makrides M; Collins CT; Gibson RA; McPhee AJ; Sullivan TR; Gould JF; Green TJ; Doyle LW; Davis PG; French NP; Colditz PB; Simmer K; Morris SA; Best KP
Am J Clin Nutr; 2019 Jun; 109(6):1600-1610. PubMed ID: 31070712
[TBL] [Abstract][Full Text] [Related]
13. Long-term effect of high-dose supplementation with DHA on visual function at school age in children born at <33 wk gestational age: results from a follow-up of a randomized controlled trial.
Molloy CS; Stokes S; Makrides M; Collins CT; Anderson PJ; Doyle LW
Am J Clin Nutr; 2016 Jan; 103(1):268-75. PubMed ID: 26537943
[TBL] [Abstract][Full Text] [Related]
14. Maternal High-Dose DHA Supplementation and Neurodevelopment at 18-22 Months of Preterm Children.
Guillot M; Synnes A; Pronovost E; Qureshi M; Daboval T; Caouette G; Olivier F; Bartholomew J; Mohamed I; Massé E; Afifi J; Hendson L; Lemyre B; Luu TM; Strueby L; Cieslak Z; Yusuf K; Pelligra G; Ducruet T; Ndiaye ABKT; Angoa G; Sériès T; Piedboeuf B; Nuyt AM; Fraser W; Mâsse B; Lacaze-Masmonteil T; Lavoie PM; Marc I
Pediatrics; 2022 Jul; 150(1):. PubMed ID: 35652296
[TBL] [Abstract][Full Text] [Related]
15. Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial.
Best KP; Sullivan TR; Gunaratne AW; Gould JF; Gibson RA; Collins CT; Makrides M; Green TJ
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678206
[TBL] [Abstract][Full Text] [Related]
16. Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial.
Hellström A; Nilsson AK; Wackernagel D; Pivodic A; Vanpee M; Sjöbom U; Hellgren G; Hallberg B; Domellöf M; Klevebro S; Hellström W; Andersson M; Lund AM; Löfqvist C; Elfvin A; Sävman K; Hansen-Pupp I; Hård AL; Smith LEH; Ley D
JAMA Pediatr; 2021 Apr; 175(4):359-367. PubMed ID: 33523106
[TBL] [Abstract][Full Text] [Related]
17. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.
Makrides M; Gibson RA; McPhee AJ; Yelland L; Quinlivan J; Ryan P;
JAMA; 2010 Oct; 304(15):1675-83. PubMed ID: 20959577
[TBL] [Abstract][Full Text] [Related]
18. Effect of two doses of docosahexaenoic acid (DHA) in the diet of preterm infants on infant fatty acid status: results from the DINO trial.
Smithers LG; Gibson RA; McPhee A; Makrides M
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):141-6. PubMed ID: 18951004
[TBL] [Abstract][Full Text] [Related]
19. DHA supplementation in infants born preterm and the effect on attention at 18 months' corrected age: follow-up of a subset of the N3RO randomised controlled trial.
Hewawasam E; Collins CT; Muhlhausler BS; Yelland LN; Smithers LG; Colombo J; Makrides M; McPhee AJ; Gould JF
Br J Nutr; 2021 Feb; 125(4):420-431. PubMed ID: 32660658
[TBL] [Abstract][Full Text] [Related]
20. High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial.
Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Bednarz JM; Best KP; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Collins CT
JAMA Pediatr; 2024 Jan; 178(1):45-54. PubMed ID: 37983037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
